Par Drugs & Chemical Current Share Price | Par Drugs & Chemical Stock Screener
PAR
Pharmaceuticals
Par Drugs & Chemical Current Stock Price Today
Live Share Price NSE
₹101.33
▼
-1.15 (-1.12%)
As of August 21, 2026, the live Par Drugs & Chemical share price (NSE: PAR) is ₹101.33, down 1.12% from the previous close, with shares trading between ₹100.10 and ₹103.65 in today's trading session, and a 52-week range of ₹78.58–₹110.81.
Analyse Par Drugs & Chemical stock price data download and track historical price performance.
Use the Par Drugs & Chemical stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Par Drugs & Chemical Market Cap
₹124.10 Cr.
PAR P/E Ratio (TTM)
8.59
Par Drugs & Chemical P/B Ratio
1.11
EPS (TTM)
₹10.65
Dividend Yield
-
Debt to Equity
-
PAR 52 Week High
₹110.81
Par Drugs & Chemical 52 Week Low
₹78.58
Operating Margin
17.00%
Profit Margin
13.39%
PAR Revenue (TTM)
₹112.00
EBITDA
₹23.00
Net Income
₹15.00
Total Assets
₹129.00
Total Equity
₹112.00
Par Drugs & Chemical Current Share Price Chart
Track the current Par Drugs & Chemical share price and stock price with an interactive chart. Analyse PAR price trends, trading volume, historical performance, and volatility across different timeframes — the complete Par Drugs & Chemical stock quote in one place.
Par Drugs & Chemical Company Profile - Fundamental Screener
Screen Par Drugs & Chemical company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE04LG01015
Par Drugs & Chemical Balance Sheet Screener
Screen PAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 129 | 119 | 102 | 89 | 79 | 76 | 60 | 51 | 54 | 56 |
| Current Assets | 64 | 55 | 60 | 49 | 44 | 41 | 24 | 14 | 14 | 14 |
| Fixed Assets | 37 | 39 | 41 | 38 | 34 | 30 | 34 | 36 | 39 | 42 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 4 | 4 | 4 | 4 | 8 | 9 | 10 | 16 | 17 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 112 | 99 | 86 | 71 | 60 | 52 | 41 | 29 | 21 | 20 |
| Share Capital | 12 | 12 | 12 | 12 | 12 | 6 | 6 | 5 | 9 | 9 |
| Reserves & Surplus | 100 | 87 | 73 | 59 | 48 | 46 | 35 | 25 | 13 | 11 |
Par Drugs & Chemical Income Statement Screener - Profit & Revenue Analysis
Screen Par Drugs & Chemical income statement and profit fundamentals.
Analyze PAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Par Drugs & Chemical share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 112 | 104 | 103 | 96 | 96 | 75 | 61 | 56 | 46 | 42 | 49 |
| Expenses | 89 | 87 | 82 | 73 | 78 | 59 | 45 | 46 | 38 | 34 | 40 |
| EBITDA | 23 | 17 | 22 | 23 | 18 | 16 | 16 | 10 | 8 | 8 | 9 |
| Operating Profit % | 17.00% | 17.00% | 19.00% | 24.00% | 19.00% | 22.00% | 26.00% | 17.00% | 18.00% | 19.00% | 18.00% |
| Depreciation | 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Profit Before Tax | 19 | 17 | 18 | 20 | 15 | 13 | 15 | 6 | 3 | 3 | 3 |
| Tax | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 2 |
| Net Profit | 15 | 13 | 13 | 15 | 11 | 9 | 12 | 5 | 3 | 2 | 2 |
| EPS | 11.80 | 10.65 | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 5.60 | 5.64 | 6.50 |
Par Drugs & Chemical Cash Flow Screener - Liquidity Fundamentals
Screen PAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 16 | 20 | 13 | 8 | 12 | 8 | 2 | 4 | 9 | 7 |
| Investing Activities | -25 | -6 | -7 | -3 | 0 | -2 | 0 | -1 | -2 | 0 |
| Financing Activities | 0 | 0 | 0 | -10 | 2 | 1 | -2 | -4 | -8 | -6 |
| Net Cash Flow | -9 | 14 | 6 | -5 | 14 | 7 | 0 | 0 | -1 | 1 |
Par Drugs & Chemical Shareholding Pattern Screener
See Par Drugs & Chemical shareholding pattern with promoter, FII, and DII holdings.
Check Par Drugs & Chemical promoter holding and ownership changes for PAR on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.41% | 73.41% | 73.37% | 73.37% | 73.37% | 73.41% | 74.21% | 74.21% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 19.97% | 19.95% | 20.30% | 20.26% | 20.27% | 20.03% | 20.46% | 20.09% |
| Other Holding | 6.62% | 6.56% | 6.33% | 6.37% | 6.37% | 6.56% | 5.34% | 5.71% |
| Shareholder Count | 13,222 | 12,782 | 15,472 | 14,887 | 14,280 | 13,761 | 7,403 | 8,022 |
Par Drugs & Chemical Share Dividend Screener - Share Yield Analysis
Check Par Drugs & Chemical dividend history with payout and yield data.
View Par Drugs & Chemical dividend details including ex-dates and amounts for PAR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹2.50 | 4.04% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Par Drugs & Chemical Stock Index Membership
See which indices include Par Drugs & Chemical stock.
Check PAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Par Drugs & Chemical Market Events Screener - Corporate Actions
Get Par Drugs & Chemical corporate actions including splits, bonuses, and buybacks.
Check Par Drugs & Chemical stock events that may affect PAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-08-08 | 2026-08-08 | Quarterly Result Announcement | NA | -0.91% |
| 2026-05-14 | 2026-05-14 | Quarterly Result Announcement | NA | 3.33% |
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 7.71% |
| 2025-12-31 | 2025-12-31 | Extraordinary General Meeting | NA | -14.97% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.43% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -8.56% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | -0.65% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -14.79% |
| 2025-02-12 | 2025-02-12 | Extraordinary General Meeting | NA | -9.70% |
| 2025-02-05 | 2025-02-05 | Extraordinary General Meeting | NA | -2.49% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | 5.27% |
| 2024-09-21 | 2024-09-21 | Annual General Meeting | NA | 2.55% |
| 2021-11-22 | 2021-11-23 | Dividend | ₹ 1.25 /share | -32.38% |
| 2021-04-27 | 2021-04-28 | Bonus | 1:1 | 3.44% |
Par Drugs & Chemical Competitors Screener - Peer Comparison
Screen PAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 455,874 | 37.16 | 61,674 | 12.69% | 11,565 | 42.22 |
| Divis Laboratories | 227,241 | 78.05 | 11,067 | 13.95% | 2,568 | 72.51 |
| Torrent Pharmaceuticals | 190,678 | 87.77 | 13,886 | 20.34% | 2,138 | 57.42 |
| Cipla | 114,876 | 34.47 | 29,045 | 2.24% | 3,870 | 41.47 |
| Zydus Life Science | 111,139 | 24.26 | 27,658 | 17.64% | 5,026 | 43.98 |
| Lupin | 101,734 | 18.33 | 29,039 | 26.75% | 5,356 | 31.49 |
| Mankind Pharma | 98,871 | 47.74 | 14,636 | 14.85% | 1,938 | 40.92 |
| Dr Reddys Laboratories | 97,656 | 30.95 | 35,059 | 3.90% | 4,158 | 41.01 |
| Laurus Labs | 97,271 | 89.91 | 6,868 | 22.01% | 890 | 62.14 |
| Aurobindo Pharma | 93,470 | 25.64 | 34,145 | 5.56% | 3,503 | 54.91 |
Par Drugs & Chemical Company Announcements - News Screener
Screen PAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-14 | Copy of Newspaper Publication | - |
| 2026-08-08 | Outcome of Board Meeting | - |
| 2026-08-08 | Outcome of Board Meeting | - |
| 2026-08-08 | Updates | - |
| 2026-07-07 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | - |
| 2026-06-25 | Trading Window | - |
| 2026-06-10 | Action(s) taken or orders passed | - |
| 2026-05-21 | Action(s) initiated or orders passed | - |
| 2026-05-15 | Copy of Newspaper Publication | - |
| 2026-05-14 | Outcome of Board Meeting | - |
| 2026-05-14 | Outcome of Board Meeting | - |
| 2026-05-14 | Outcome of Board Meeting | - |
| 2026-05-14 | Updates | - |
| 2026-05-14 | Updates | - |
| 2026-04-08 | Disclosure under SEBI Takeover Regulations | - |
| 2026-04-07 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | - |
| 2026-03-26 | Action(s) taken or orders passed | - |
| 2026-03-26 | Trading Window | - |
| 2026-02-11 | Copy of Newspaper Publication | - |
| 2026-02-10 | Updates | - |